(a) Exposure amount--(1) Single OTC derivative contract. Except as modified by paragraph (b) of this section, the exposure amount for a single OTC derivative contract that is not subject to a qualifying master netting agreement is equal to the sum of the Board-regulated institution's current credit exposure and potential future credit exposure (PFE) on the OTC derivative contract.
(1) Single OTC derivative contract. Except as modified by paragraph (b) of this section, the exposure amount for a single OTC derivative contract that is not subject to a qualifying master netting agreement is equal to the sum of the Board-regulated institution's current credit exposure and potential future credit exposure (PFE) on the OTC derivative contract.
(i) Current credit exposure. The current credit exposure for a single OTC derivative contract is the greater of the mark-to-fair value of the OTC derivative contract or zero.
(ii) PFE. (A) The PFE for a single OTC derivative contract, including an OTC derivative contract with a negative mark-to-fair value, is calculated by multiplying the notional principal amount of the OTC derivative contract by the appropriate conversion factor in Table 1 to Sec. 217.34.
(A) The PFE for a single OTC derivative contract, including an OTC derivative contract with a negative mark-to-fair value, is calculated by multiplying the notional principal amount of the OTC derivative contract by the appropriate conversion factor in Table 1 to Sec. 217.34.
(B) For purposes of calculating either the PFE under this paragraph (a) or the gross PFE under paragraph (a)(2) of this section for exchange rate contracts and other similar contracts in which the notional principal amount is equivalent to the cash flows, notional principal amount is the net receipts to each party falling due on each value date in each currency.
(C) For an OTC derivative contract that does not fall within one of the specified categories in Table 1 to Sec. 217.34, the PFE must be calculated using the appropriate ``other'' conversion factor.
(D) A Board-regulated institution must use an OTC derivative contract's effective notional principal amount (that is, the apparent or stated notional principal amount multiplied by any multiplier in the OTC derivative contract) rather than the apparent or stated notional principal amount in calculating PFE.
(E) The PFE of the protection provider of a credit derivative is capped at the net present value of the amount of unpaid premiums.
Table 1 to Sec. 217.34--Conversion Factor Matrix for Derivative Contracts\1\--------------------------------------------------------------------------------------------------------------------------------------------------------
Credit
Interest Foreign (investment Credit (non- Precious
Remaining maturity \2\ rate exchange rate grade reference investment-grade Equity metals (except Other
and gold asset) \3\ reference asset) gold)--------------------------------------------------------------------------------------------------------------------------------------------------------One year or less......................................... 0.00 0.01 0.05 0.10 0.06 0.07 0.10Greater than one year and less than or equal to five 0.005 0.05 0.05 0.10 0.08 0.07 0.12
years...................................................Greater than five years.................................. 0.015 0.075 0.05 0.10 0.10 0.08 0.15--------------------------------------------------------------------------------------------------------------------------------------------------------\1\ For a derivative contract with multiple exchanges of principal, the conversion factor is multiplied by the number of remaining payments in the
derivative contract.\2\ For an OTC derivative contract that is structured such that on specified dates any outstanding exposure is settled and the terms are reset so that
the fair value of the contract is zero, the remaining maturity equals the time until the next reset date. For an interest rate derivative contract
with a remaining maturity of greater than one year that meets these criteria, the minimum conversion factor is 0.005.\3\ A Board-regulated institution must use the column labeled ``Credit (investment-grade reference asset)'' for a credit derivative whose reference
asset is an outstanding unsecured long-term debt security without credit enhancement that is investment grade. A Board-regulated institution must use
the column labeled ``Credit (non-investment-grade reference asset)'' for all other credit derivatives.
(2) Multiple OTC derivative contracts subject to a qualifying master netting agreement. Except as modified by paragraph (b) of this section, the exposure amount for multiple OTC derivative contracts subject to a qualifying master netting agreement is equal to the sum of the net current credit exposure and the adjusted sum of the PFE amounts for all OTC derivative contracts subject to the qualifying master netting agreement.
(i) Net current credit exposure. The net current credit exposure is the greater of the net sum of all positive and negative mark-to-fair values of the individual OTC derivative contracts subject to the qualifying master netting agreement or zero.
(ii) Adjusted sum of the PFE amounts. The adjusted sum of the PFE amounts, Anet, is calculated as Anet = (0.4 x Agross) + (0.6 x NGR x Agross), where:
(A) Agross = the gross PFE (that is, the sum of the PFE amounts as determined under paragraph (a)(1)(ii) of this section for each individual derivative contract subject to the qualifying master netting agreement); and
(B) Net-to-gross Ratio (NGR) = the ratio of the net current credit exposure to the gross current credit exposure. In calculating the NGR, the gross current credit exposure equals the sum of the positive current credit exposures (as determined under paragraph (a)(1)(i) of this section) of all individual derivative contracts subject to the qualifying master netting agreement.
(b) Recognition of credit risk mitigation of collateralized OTC derivative contracts: (1) A Board-regulated institution may recognize the credit risk mitigation benefits of financial collateral that secures an OTC derivative contract or multiple OTC derivative contracts subject to a qualifying master netting agreement (netting set) by using the simple approach in Sec. 217.37(b).
(2) As an alternative to the simple approach, a Board-regulated institution may recognize the credit risk mitigation benefits of financial collateral that secures such a contract or netting set if the financial collateral is marked-to-fair value on a daily basis and subject to a daily margin maintenance requirement by applying a risk weight to the exposure as if it were uncollateralized and adjusting the exposure amount calculated under paragraph (a)(1) or (2) of this section using the collateral haircut approach in Sec. 217.37(c). The Board-regulated institution must substitute the exposure amount calculated under paragraph (a)(1) or (2) of this section for [Sigma]E in the equation in Sec. 217.37(c)(2).
(c) Counterparty credit risk for OTC credit derivatives. (1) Protection purchasers. A Board-regulated institution that purchases an OTC credit derivative that is recognized under Sec. 217.36 as a credit risk mitigant for an exposure that is not a covered position under subpart F is not required to compute a separate counterparty credit risk capital requirement under Sec. 217.32 provided that the Board-regulated institution does so consistently for all such credit derivatives. The Board-regulated institution must either include all or exclude all such credit derivatives that are subject to a qualifying master netting agreement from any measure used to determine counterparty credit risk exposure to all relevant counterparties for risk-based capital purposes.
(1) Protection purchasers. A Board-regulated institution that purchases an OTC credit derivative that is recognized under Sec. 217.36 as a credit risk mitigant for an exposure that is not a covered position under subpart F is not required to compute a separate counterparty credit risk capital requirement under Sec. 217.32 provided that the Board-regulated institution does so consistently for all such credit derivatives. The Board-regulated institution must either include all or exclude all such credit derivatives that are subject to a qualifying master netting agreement from any measure used to determine counterparty credit risk exposure to all relevant counterparties for risk-based capital purposes.
(2) Protection providers. (i) A Board-regulated institution that is the protection provider under an OTC credit derivative must treat the OTC credit derivative as an exposure to the underlying reference asset. The Board-regulated institution is not required to compute a counterparty credit risk capital requirement for the OTC credit derivative under Sec. 217.32, provided that this treatment is applied consistently for all such OTC credit derivatives. The Board-regulated institution must either include all or exclude all such OTC credit derivatives that are subject to a qualifying master netting agreement from any measure used to determine counterparty credit risk exposure.
(i) A Board-regulated institution that is the protection provider under an OTC credit derivative must treat the OTC credit derivative as an exposure to the underlying reference asset. The Board-regulated institution is not required to compute a counterparty credit risk capital requirement for the OTC credit derivative under Sec. 217.32, provided that this treatment is applied consistently for all such OTC credit derivatives. The Board-regulated institution must either include all or exclude all such OTC credit derivatives that are subject to a qualifying master netting agreement from any measure used to determine counterparty credit risk exposure.
(ii) The provisions of this paragraph (c)(2) apply to all relevant counterparties for risk-based capital purposes unless the Board-regulated institution is treating the OTC credit derivative as a covered position under subpart F, in which case the Board-regulated institution must compute a supplemental counterparty credit risk capital requirement under this section.
(d) Counterparty credit risk for OTC equity derivatives. (1) A Board-regulated institution must treat an OTC equity derivative contract as an equity exposure and compute a risk-weighted asset amount for the OTC equity derivative contract under Sec. Sec. 217.51 through 217.53 (unless the Board-regulated institution is treating the contract as a covered position under subpart F of this part).
(1) A Board-regulated institution must treat an OTC equity derivative contract as an equity exposure and compute a risk-weighted asset amount for the OTC equity derivative contract under Sec. Sec. 217.51 through 217.53 (unless the Board-regulated institution is treating the contract as a covered position under subpart F of this part).
(2) In addition, the Board-regulated institution must also calculate a risk-based capital requirement for the counterparty credit risk of an OTC equity derivative contract under this section if the Board-regulated institution is treating the contract as a covered position under subpart F of this part.
(3) If the Board-regulated institution risk weights the contract under the Simple Risk-Weight Approach (SRWA) in Sec. 217.52, the Board-regulated institution may choose not to hold risk-based capital against the counterparty credit risk of the OTC equity derivative contract, as long as it does so for all such contracts. Where the OTC equity derivative contracts are subject to a qualified master netting agreement, a Board-regulated institution using the SRWA must either include all or exclude all of the contracts from any measure used to determine counterparty credit risk exposure.
(e) Clearing member Board-regulated institution's exposure amount. A clearing member Board-regulated institution's exposure amount for an OTC derivative contract or netting set of OTC derivative contracts where the Board-regulated institution is either acting as a financial intermediary and enters into an offsetting transaction with a QCCP or where the Board-regulated institution provides a guarantee to the QCCP on the performance of the client equals the exposure amount calculated according to paragraph (a)(1) or (2) of this section multiplied by the scaling factor 0.71. If the Board-regulated institution determines that a longer period is appropriate, the Board-regulated institution must use a larger scaling factor to adjust for a longer holding period as follows: [GRAPHIC] [TIFF OMITTED] TR11OC13.015 where H = the holding period greater than five days. Additionally, the Board
may require the Board-regulated institution to set a longer
holding period if the Board determines that a longer period is
appropriate due to the nature, structure, or characteristics
of the transaction or is commensurate with the risks
associated with the transaction.